Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Medistem logo — company profile

Medistem

Founded 2005 Series A Biotechnology

General Information

Company Name Medistem
Founded Year 2005
Industries Biotechnology
Funding Stage Series A
Social

Get notified when Medistem moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Medistem

Medistem is a biotechnology startup, founded in 2005, that specializes in the development, acquisition, and commercialization of adult stem cell-based therapeutic products. The company holds 16 patent application families and has numerous scientific publications to its name. It has also out-licensed certain technologies to generate revenue. Medistem's flagship product is the Endometrial Regenerative Cell, a universal donor pluripotent stem cell. This product is currently under development to address critical limb ischemia, an advanced form of peripheral artery disease. The most recent investment in Medistem was a Series A investment on February 1, 2012, with the investor being Alex Tellez. Overall, Medistem's focus on cutting-edge biotechnology and its promising product pipeline make it an intriguing prospect for potential investors seeking exposure to the burgeoning field of stem cell therapy.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 01 Feb 2012

Medistem Alternatives & Competitors

Medistem vs
GIOSTAR
GIOSTAR United States

Pioneers In Innovative Stem Cell Science and Therapy

9 employees
Medistem vs
Kangstem Biotech Co., Ltd.
Kangstem Biotech Co., Ltd.

To become World Top Stem Cell Company, all executives and employees are preparing for a 'better tomo...

23 employees
Biotechnology, Health Care
Medistem vs
深圳爱生再生医学科技有限公司
深圳爱生再生医学科技有限公司

Pioneering biomedical advancements with innovative cell engineering solutions for the future of heal...

Angel
5 employees
Biotechnology, Health Care

FAQ About Medistem

Founded in 2005, MediStem focuses on developing, acquiring, and commercializing adult stem cell-based therapeutic products. With 16 patent application families and numerous scientific publications, the company has out-licensed certain technologies to generate revenue. MediStem’s primary candidate, t...
Medistem was founded in 2005.
Medistem operates in the following industries: Biotechnology.
Medistem has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to Medistem include GIOSTAR, Kangstem Biotech Co., Ltd., 深圳爱生再生医学科技有限公司, Stem Cell Cure India, HEROSTEM BIOTECHNOLOGY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medistem and GIOSTAR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Medistem and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy